Treatment-free survival over extended follow-up of patients with advanced melanoma treated with immune checkpoint inhibitors in CheckMate 067 by Regan, Meredith M, Mantia, Charlene M, Werner, Lillian, Tarhini, Ahmad A, Larkin, James, Stephen Hodi, F, Wolchok, Jedd, Postow, Michael A, Stwalley, Brian, Moshyk, Andriy, Ritchings, Corey, Re, Sandra, van Dijck, Wim, McDermott, David F, Atkins, Michael B

Get full text

Vascular endothelial growth factor and programmed death‐1 pathway inhibitors in renal cell carcinoma by Mantia, Charlene M., McDermott, David F.

Get full text

Treatment-free survival and partitioned survival analysis of patients with advanced renal cell carcinoma treated with nivolumab plus ipilimumab versus sunitinib: 5-year update of C... by Mantia, Charlene M, Jegede, Opeyemi A, Plimack, Elizabeth R, Powles, Thomas, Motzer, Robert J, Tannir, Nizar M, Lee, Chung-Han, Tomita, Yoshihiko, Voss, Martin H, Choueiri, Toni K, Rini, Brian I, Hammers, Hans J, Escudier, Bernard, Albigès, Laurence, Rosenblatt, Lisa, Atkins, Michael B, Regan, Meredith M, McDermott, David F

Get full text

Treatment-free Survival after Immune Checkpoint Inhibitor Therapy versus Targeted Therapy for Advanced Renal Cell Carcinoma: 42-Month Results of the CheckMate 214 Trial by Regan, Meredith M, Jegede, Opeyemi A, Mantia, Charlene M, Powles, Thomas, Werner, Lillian, Motzer, Robert J, Tannir, Nizar M, Lee, Chung-Han, Tomita, Yoshihiko, Voss, Martin H, Plimack, Elizabeth R, Choueiri, Toni K, Rini, Brian I, Hammers, Hans J, Escudier, Bernard, Albiges, Laurence, Huo, Stephen, Del Tejo, Viviana, Stwalley, Brian, Atkins, Michael B, McDermott, David F

Get full text

VEGF and PD-1 pathway inhibitors in renal cell carcinoma by Mantia, Charlene M., McDermott, David F.

Get full text

Treatment-Free Survival after Immune Checkpoint Inhibitor Therapy vs. Targeted Therapy for Advanced Renal Cell Carcinoma: 42-Month Results of the CheckMate 214 Trial by Regan, Meredith M., Jegede, Opeyemi A., Mantia, Charlene M., Powles, Thomas, Werner, Lillian, Motzer, Robert J., Tannir, Nizar M., Lee, Chung-Han, Tomita, Yoshihiko, Voss, Martin H., Plimack, Elizabeth R., Choueiri, Toni K., Rini, Brian I., Hammers, Hans J., Escudier, Bernard, Albiges, Laurence, Huo, Stephen, Del Tejo, Viviana, Stwalley, Brian, Atkins, Michael B., McDermott, David F.

Get full text

Abstract 1137: Determination of a recommended Phase 2 dose (RP2D) for SRF388, a first-in-class IL-27-blocking antibody, in patients with advanced solid tumors by Hill, Jonathan A., White, Kerry F., Rausch, Matthew, Chung, Jou-Ku, Patnaik, Amita, Naing, Aung, Morgensztern, Daniel, Mantia, Charlene M., Tannir, Nizar M., Smith, Lon S., Bowers, Beth, Alika, Alex, Harshman, Lauren C., Lee, Benjamin H.

Get full text

Predicting the higher rate of intracranial hemorrhage in glioma patients receiving therapeutic enoxaparin by Mantia, Charlene, Uhlmann, Erik J., Puligandla, Maneka, Weber, Griffin M., Neuberg, Donna, Zwicker, Jeffrey I.

Get full text

Recurrent Intracranial Hemorrhage and Venous Thromboembolism Following Initial Intracranial Hemorrhage in Patients with Brain Tumors on Anticoagulation by Carney, Brian J., Uhlmann, Erik J., Puligandla, Maneka, Mantia, Charlene, Weber, Griffin M., Neuberg, Donna S, Zwicker, Jeffrey I.

Get full text

Anticoagulation after intracranial hemorrhage in brain tumors: Risk of recurrent hemorrhage and venous thromboembolism by Carney, Brian J., Uhlmann, Erik J., Puligandla, Maneka, Mantia, Charlene, Weber, Griffin M., Neuberg, Donna S., Zwicker, Jeffrey I.

Get full text

Safety of Direct-Acting Oral Anticoagulants Versus Enoxaparin in Patients with Primary and Metastatic Brain Tumors by Carney, Brian J., Uhlmann, Erik J., Puligandla, Maneka, Mantia, Charlene, Weber, Griffin M., Neuberg, Donna S, Zwicker, Jeffrey I.

Get full text

Intracranial Hemorrhage in Patients with Primary Brain Tumors Treated with Therapeutic Enoxaparin: A Matched Cohort Study by Mantia, Charlene, Uhlmann, Erik, Puligandla, Maneka, Neuberg, Donna S., Weber, Griffin M., Zwicker, Jeffrey I.

Get full text